Glenmede Trust CO Na Sarepta Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 2,297 shares of SRPT stock, worth $249,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,297

Previous 2,338 1.75%

Holding current value

$249,017

Previous $292,000 4.45%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.54 - $137.94 $4,286 - $5,655	-41 Reduced 1.75%	2,297 $279,000
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $5,843 - $7,367	47 Added 2.05%	2,338 $292,000
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $38,758 - $56,036	-342 Reduced 12.99%	2,291 $361,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $21,176 - $31,985	226 Added 9.39%	2,633 $340,000
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $6,259 - $11,602	93 Added 4.02%	2,407 $232,000
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $7,892 - $9,516	77 Added 3.44%	2,314 $280,000
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $470 - $623	-4 Reduced 0.18%	2,237 $308,000
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $3,328 - $4,360	33 Added 1.49%	2,241 $290,000
Q3 2022 Nov 16, 2022	BUY	$75.71 - $119.24 $167,167 - $263,281	2,208 New	2,208 $243,000
Q1 2021 May 18, 2021	SELL	$72.25 - $168.95 $146,089 - $341,616	-2,022 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $13,058 - $18,588	-104 Reduced 4.89%	2,022 $343,000
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $254 - $344	-2 Reduced 0.09%	2,126 $297,000
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $1,767 - $3,262	19 Added 0.9%	2,128 $340,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $291 - $627	-4 Reduced 0.19%	2,109 $158,000
Q1 2019 May 14, 2019	BUY	$106.67 - $151.68 $10,667 - $15,168	100 Added 4.97%	2,113 $251,000
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $1,265 - $1,933	13 Added 0.65%	2,013 $219,000
Q2 2018 Aug 15, 2018	SELL	$71.74 - $153.69 $21,522 - $46,107	-300 Reduced 13.04%	2,000 $264,000
Q4 2017 Feb 15, 2018	BUY	$47.64 - $56.75 $14,292 - $17,025	300 Added 15.0%	2,300 $127,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $71,460 - $94,300	2,000	2,000 $0

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Sarepta Therapeutics, Inc. Transaction History